RAPT Therapeutics, Inc. (RAPT) Cash from Operations (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Cash from Operations for 5 consecutive years, with 10437000.0 as the latest value for Q4 2024.
- Quarterly Cash from Operations rose 62.39% to 10437000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was 83297000.0 through Dec 2024, up 14.17% year-over-year, with the annual reading at 83297000.0 for FY2024, 14.17% up from the prior year.
- Cash from Operations hit 10437000.0 in Q4 2024 for RAPT Therapeutics, up from 17622000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 6427000.0 in Q2 2020 to a low of 28808000.0 in Q2 2023.
- Historically, Cash from Operations has averaged 17631650.0 across 5 years, with a median of 16363500.0 in 2022.
- Biggest five-year swings in Cash from Operations: plummeted 116.52% in 2021 and later soared 62.39% in 2024.
- Year by year, Cash from Operations stood at 15366000.0 in 2020, then plummeted by 34.59% to 20681000.0 in 2021, then decreased by 10.48% to 22849000.0 in 2022, then fell by 21.47% to 27754000.0 in 2023, then skyrocketed by 62.39% to 10437000.0 in 2024.
- Business Quant data shows Cash from Operations for RAPT at 10437000.0 in Q4 2024, 17622000.0 in Q3 2024, and 28154000.0 in Q2 2024.